These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36639319)

  • 21. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.
    Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F
    Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [COPPER METABOLISM AND WILSON'S DISEASE].
    LANGE J
    Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
    BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
    Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
    [No Abstract]   [Full Text] [Related]  

  • 24. Ceruloplasmin, copper and Wilson's disease.
    KAWAI T
    Bull Univ Miami Sch Med Jackson Meml Hosp; 1962; 16():89-96. PubMed ID: 14031483
    [No Abstract]   [Full Text] [Related]  

  • 25. The diagnosis of Wilson's disease in asymptomatic patients.
    STERNLIEB I; SCHEINBERG IH
    JAMA; 1963 Mar; 183():747-50. PubMed ID: 13983986
    [No Abstract]   [Full Text] [Related]  

  • 26. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
    Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
    J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers for diagnosis of Wilson's disease.
    Ryan A; Nevitt SJ; Tuohy O; Cook P
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor.
    Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Yamamoto S; Ogawa A; Kohno Y; Sunaga M; Shimazu M; Tanaka K
    Hepatogastroenterology; 2001; 48(41):1259-61. PubMed ID: 11677941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 31. Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats.
    Muramatsu Y; Yamada T; Miura M; Sakai T; Suzuki Y; Serikawa T; Tanzi RE; Matsumoto K
    Gastroenterology; 1994 Oct; 107(4):1189-92. PubMed ID: 7926469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic aspects of Wilson's disease: a review.
    SIMPSON JF
    Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
    [No Abstract]   [Full Text] [Related]  

  • 33. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings.
    Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G
    Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatolenticular degeneration. Wilson's disease].
    Hansen HJ; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1301-5. PubMed ID: 4898805
    [No Abstract]   [Full Text] [Related]  

  • 35. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aspects of chemical pathology in 2 cases of Wilson's disease].
    Alloro L; Pecorari T
    Riv Sper Freniatr Med Leg Alien Ment; 1968 Oct; 92(5):1381-401. PubMed ID: 5738558
    [No Abstract]   [Full Text] [Related]  

  • 37. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
    HELLER GL
    Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
    [No Abstract]   [Full Text] [Related]  

  • 38. Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease.
    Oga M; Matsui N; Anai T; Yoshimatsu J; Inoue I; Miyakawa I
    Am J Obstet Gynecol; 1993 Jul; 169(1):196-8. PubMed ID: 8333453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case.
    Toaff R; Toaff ME; Peyser MR; Streifler M
    Obstet Gynecol Surv; 1977 Aug; 32(8):497-507. PubMed ID: 331163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.
    Williams AO
    Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.